Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
NCT ID: NCT00954746
Last Updated: 2015-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
645 participants
OBSERVATIONAL
2009-07-31
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease
NCT00528424
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
NCT02193828
Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures
NCT01674634
Administration of Two Injections for Multiple Dupuytren's Contractures
NCT01407068
Retreatment of Recurrent Dupuytren's Contractures
NCT01498640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Follow-up
Subjects Previously Treated with AA4500
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have received at least one injection of AA4500 in one of the Auxilium sponsored studies (AUX-CC-854, AUX-CC-856, Studies AUX-CC-857/AUX-CC-858, or AUX-CC-859) and have at least one fixed-flexion contracture measurement after treatment with AA4500
* Be able and willing to comply with the yearly assessments outlined in the protocol, as determined by the investigator
* Voluntarily sign and date an informed consent agreement approved by the Institutional Review Board/Independent Ethics Committee (IRB/IEC)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Endo Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veronica Urdaneta, MD
Role: STUDY_DIRECTOR
Endo Health Solutions
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hope Research Institute
Phoenix, Arizona, United States
Tucson Orthopedic Institute, P.C.
Tucson, Arizona, United States
Providence Clinical Research
Burbank, California, United States
100 UCLA Medical Plaza, Suite 305
Los Angeles, California, United States
Hand Surgery Clinic
Palo Alto, California, United States
The Hand and Upper Extremity Center of Georgia, P.C.
Atlanta, Georgia, United States
Southern Illinois Hand Center, S.C.
Effingham, Illinois, United States
Rockford Orthopedic Associates, Ltd.
Rockford, Illinois, United States
The Indiana Hand Center
Indianapolis, Indiana, United States
Via Christi Research
Wichita, Kansas, United States
Brigham and Women's Hospital, Department of Orthopedic Surgery
Boston, Massachusetts, United States
Newton-Wellesley Hospital
Newton, Massachusetts, United States
Marquette General Health System
Marquette, Michigan, United States
TRIA Orthopaedic Center
Minneapolis, Minnesota, United States
Hospital for Special Surgery
New York, New York, United States
SUNY Stony Brook - Department of Orthopedics
Stony Brook, New York, United States
The Bone and Joint Center
Bismarck, North Dakota, United States
Health Research Institute
Oklahoma City, Oklahoma, United States
Hand Microsurgery & Reconstructive Orthopedics
Erie, Pennsylvania, United States
University Orthopedics Center
State College, Pennsylvania, United States
University Orthopedics, Inc.
Providence, Rhode Island, United States
Alpha Clinical Research
Clarksville, Tennessee, United States
Accurate Clincal Research
Houston, Texas, United States
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Rivercity Hospital
Auchenflower, Queensland, Australia
Caboolture Clinical Research Centre
Caboolture, Queensland, Australia
Peninsula Clinical Research
Kippa-Ring, Queensland, Australia
Menzies Research Institute
Hobart, Tasmania, Australia
Emeritus Research
Malvern, Victoria, Australia
Gentofte Hospital
Hellerup, Copenhagen, Denmark
Hospital of Aalborg
Aalborg, , Denmark
Rigshospitalet
Copenhagen, , Denmark
Dextra
Helsinki, , Finland
Koskiklinikka
Tampere, , Finland
Department of Hand Surgery
Malmo, , Sweden
Department of Hand Surgery, Akademiska University Hospital
Uppsala, , Sweden
Pulvertaft Hand Clinic
Derby, Derbyshire, United Kingdom
Newcastle Biomedicine Clinical Research Facility
Newcastle, Newcastle Upon Tyne, United Kingdom
Welsh Centre for Plastic Surgery Morriston Hospital
Swansea, Wales, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUX-CC-860
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.